Vera V. Knyshova

Vera V. Knyshova

Auto-generated profile, based on publicly available information

Vera V. Knyshova

Research Institute of Medical Climatology and Rehabilitation Treatment, Far Eastern Scientific Center of Physiology and Pathology of Respiration

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2013 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
TNTatyana P. Novgorodtseva
Tatyana P. Novgorodtseva
YDYulia Denisenko
Yulia Denisenko
NZNatalia Zhukova
Natalia Zhukova
MAMarina V. Antonyuk
Marina V. Antonyuk
VKVera V. Knyshova
Vera V. Knyshova
TGTatyana A. Gvozdenko
Tatyana A. Gvozdenko
Background: Early preclinical diagnosis of COPD is urgent. We proposed that fatty acid composition of red blood cells may serve as a prognostic test for the complications in the chronic respiratory diseases. Fatty acid composition of the erythrocyte membranes in patients with chronic respiratory diseases (chronic bronchitis, CB, and stable chronic obstructive pulmonary disease, COPD) was studied. It was established that modification of the fatty acid composition in the erythrocyte membranes was unidirectional in both groups of patients. Methods: Patients with CB and stable COPD (group A, GOLD 1) (15 subjects in each group) were studied in clinic. The activity of the inflammatory process was evaluated by the phagocytic activity of neutrophils, cytokine levels and cytokine receptors in the blood serum (TNFα, sTNF-RI, bFGF, TGF-β, IL-8). Fatty acid (FA) composition of the erythrocyte membranes was analyzed by gas liquid chromatography. Statistical data processing was performed by the methods of descriptive statistics with Statistica 6.0. Results: In both groups (CB and COPD), a significant accumulation of the saturated FAs (14:0, 15:0, 18:0) was established. The amount of the arachidonic acid (20:4n-6) was increased by 13% (р < 0.05) in CB patients and by 41% (р < 0.001) in COPD patients, as compared with healthy persons. The elevated level of the PUFA n-6 in the erythrocytes membranes in patients with chronic respiratory diseases confirms that proinflammatory (leukotriene B4) and bronchospasm (prostaglandin D2) mediator substrates is increased. The level of the eicosapentaenoic acid (20:5n-3) was decreased by 32% (р < 0.05) in CB patients and 2-fold (р < 0.001) in COPD patients. The observed increase in the 20:4n-6/20:5n-3 ratio - 1.5-fold (р < 0.001) in CB patients and 3-fold in COPD patients - can be a specific marker of the adverse course of the respiratory pathology and the chronic inflammatory development. Conclusions: Chronic respiratory disease development is associated with the disturbance of the fatty acid composition in erythrocyte membranes and disbalance of the ratio between precursor of pro- and antiinflammatory eicosanoids.

31 August 2016 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
EKElena P. Kalinina
Elena P. Kalinina
YDYulia Denisenko
Yulia Denisenko
TVTat'yana I. Vitkina
Tat'yana I. Vitkina
ELElena G. Lobanova
Elena G. Lobanova
TNTatyana P. Novgorodtseva
Tatyana P. Novgorodtseva
ANAnna V. Nazarenko
Anna V. Nazarenko
Background. Comorbidity of chronic obstructive pulmonary disease (COPD) and asthma (asthma COPD overlap syndrome, ACOS) is a significant problem in pulmonary practice, whose pathogenetic issues are not clarified yet.Objective. To study the features of the regulation of immune response in patients with comorbid COPD and asthma.Methods. We assessed the levels of CD3+, CD4+, CD8+, CD4+/CD8+, CD19+, CD25+, HLA-DR, total IgE, TNF-α, IL-4, IFN-γ, TXB2, and LTB4in patients with comorbid COPD and asthma.Results. The study involved 44 people with COPD, 39 people with asthma, and 12 people with comorbid COPD and asthma. The specific features in comorbid COPD and asthma were lymphocytosis, increased absolute count of T-helper cells, increased cytotoxic T-lymphocytes in relative and absolute count, increased relative and absolute numbers of B-lymphocytes, and high levels of total IgE. The elevated levels of TNF-αand IL-4 and inhibition of IFN-γproduction were detected. The content of LTB4was maximal; TXB2levels were higher than in control group but lower than in COPD and asthma.Conclusion. In comorbid COPD and asthma inflammation increased even during stable period. High levels of eicosanoids, low production of Th1-type cytokines, and active synthesis of opposition IL-4, along with increased IgE, indicate the activation of Th2-type immune response.

7 March 2019 in Russian Open Medical Journal
Verified
Journal Article
Open access
TNTatyana P. Novgorodtseva
Tatyana P. Novgorodtseva
TGTatyana A. Gvozdenko
Tatyana A. Gvozdenko
TVTat'yana I. Vitkina
Tat'yana I. Vitkina
YDYulia Denisenko
Yulia Denisenko
MAMarina V. Antonyuk
Marina V. Antonyuk
VKVera V. Knyshova
Vera V. Knyshova
At present time, the pathogenesis of various diseases is considered in terms of typical pathological processes. One of the main typical pathological processes is inflammation, a universal complex of genetically programmed reactions to any phologogenic agents. Pathophysiological changes in chronic respiratory diseases are caused by local inflammation in the airways that results in bronchial obstruction, destructive processes in the lung parenchyma, remodeling of the lung tissue and disruption of gas exchange [1-3].

15 December 2018 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
EKE. P. Kalinina
E. P. Kalinina
TVT. I. Vitkina
T. I. Vitkina
VKV. V. Knyshova
V. V. Knyshova
EFE. A. Fedoseeva
E. A. Fedoseeva
TNT. P. Novgorodtseva
T. P. Novgorodtseva
TGT. A. Gvozdenko
T. A. Gvozdenko
Хроническая обструктивная болезнь легких (ХОБЛ) является глобальной проблемой здравоохранения. Актуальным является изучение иммунологических особенностей и их сопряженности с клиническим течением ХОБЛ. Цель исследования – установить клинико-иммунологические особенности ХОБЛ разной степени тяжести при Th1- и Тh17-зависимых типах иммунного ответа. Обследовано 132 пациента с ХОБЛ и 32 практически здоровых лица. По клинико-функциональным вариантам пациенты с ХОБЛ разделены по группам: 36 человек (28%) с легкой степенью тяжести, 62 человека (48%) со средней степенью тяжести и 30 человек (23%) с тяжелой степенью тяжести. Проводилось клинико-функциональное и лабораторное исследование. Субпопуляции Th1- и Th17- лимфоцитов оценивали по уровню цитокинов в сыворотке крови (туморнекротизирующий фактор (TNFα), интерлейкинов (IL) IL-4, IL-10, IL-17А, IL-21, IFNγ), трансформирующего фактора роста β1 (TGF-β1)), определяли экспрессию рецептора IL-6R (CD126+) на зрелых Т-лимфоцитах (CD3+) и Т-хелперах (CD4+) периферической крови. Результаты исследования показали, что у больных ХОБЛ легкой степени тяжести определялись три разных фенотипа с превалированием Th1-зависимого иммунного ответа. Уровень экспрессии IL-6R представлен в большей степени на CD3+CD126+ клетках при Th1/Th17-фенотипе и CD4+CD126+ клетках при Th17-зависимом типе иммунного ответа. У больных ХОБЛ средней степени тяжести соотношение между Th1-, Th17- и Th1/Th17-типами иммунного ответа определялось в равных долях. Уровень экспрессии IL-6R на зрелых Т-лимфоцитах и Т-хелперах возрастает в наибольшей степени при Th17-зависимом иммунном ответе. У больных ХОБЛ тяжелой степени преобладал иммунный ответ по Th17- и Th1/Th17-типам. Уровень экспрессии IL-6R увеличивается при Th17- и Th1/Th17- зависимых типах иммунного ответа, при этом наиболее значимое возрастание отмечается для CD4+ клеток при Th17-фенотипе. Установлено, что с фенотипами иммунного ответа у пациентов с ХОБЛ сопряжены особенности клинического течения заболевания. Полученные данные позволят определить фенотип воспаления, спрогнозировать течение хронического заболевания и подобрать адекватную терапию.

15 December 2018 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
MAM. V. Antonyuk
M. V. Antonyuk
TGT. A. Gvozdenko
T. A. Gvozdenko
TNT. P. Novgorodtseva
T. P. Novgorodtseva
TVT. I. Vitkina
T. I. Vitkina
BGB. I. Geltser
B. I. Geltser
VKV. V. Knyshova
V. V. Knyshova
Combination of bronchial asthma (BA) and obesity is a difficult-to-control phenotype. Studies of inflammatory process with respect to severity of the disease are important for understanding the potential influence of obesity on the BA clinical course. The objective of this study was to determine cytokine profile in patients with mild BA combined with obesity. The study involved fifty-three patients with partially controlled mild BA. The patients were recruited as volunteers and signed an informed consent. The first observation group consisted of 27 asthma patients with normal body weight, the second observation group consisted of 26 patients with BA combined with obesity. A control group included 25 healthy volunteers. All the patients underwent clinical and laboratory examination in accordance with clinical standards for BA and obesity. The levels of TNFα, IL-2, IL-4, IL-6, IL-10 were evaluated in blood serum by means of flow cytometry. The ratios of proand anti-inflammatory cytokines (TNFα/IL-4, TNFα/IL-10, IL-6/IL-4, IL-6/IL-10) were calculated. Asthma patients with obesity (the 2nd group) had elevated levels of IL-2 over control group and group 1, by 38% and 44% respectively(p < 0.05). The concentration of proinflammatory cytokines TNFα and IL-6 was significanty increased in the both patient groups. Mean TNFα level was increased 2.5 times (p < 0.05), and IL-6 levels were increased by 30% (p < 0.05) in the 1st group as compared to the controls. TNFα and IL-6 concentrations showed a 3-fold increase over control values (p < 0.05) in the 2nd group. The level of antiinflammatory cytokine IL-4 was increased in patients with BA, independently of body mass. It should be noted that the concentration of this cytokine in obese patients was higher by 29% than in patients with normal body weight. IL-10 levels in patients from the 2nd group were reduced more than 2 times than in the 1st group. The patients of the 1st group showed a decrease in the IL-6/IL-10 index, in comparison with control parameters, thus indicative of an imbalance due to the elevation of the anti-inflammatory IL-10 cytokine. Among BA patients with obesity (group 2) the TNFα/IL-10 and IL-6/IL-10 indexes were higher than those of the control group (2.3- and 5.5-fold, respectively) and the group 1 (2.6- and 2.5-fold, respectively). Dynamics of these indexes confirms the systemic nature of inflammation and a predominance of non-atopic inflammation in asthma patients with obesity. Thus, features of the cytokine profile in BA with obesity consist of a significant increase in pro-inflammatory IL-2, IL-6, TNFα cytokines, and a relative decrease in anti-inflammatory IL- 10 cytokine. The development of BA with obesity, even in mild-severity BA, is accompanied by development of a cytokine disbalance, which is typical for a mixed-type inflammation, with a prevalence of neutrophil inflammation.

20 December 2022 in Russian Open Medical Journal
Verified
Journal Article
Closed access
YDYulia Denisenko
Yulia Denisenko
TNTatyana P. Novgorodtseva
Tatyana P. Novgorodtseva
TVTat'yana I. Vitkina
Tat'yana I. Vitkina
VKVera V. Knyshova
Vera V. Knyshova
MAMarina V. Antonyuk
Marina V. Antonyuk
OKOxana Kytikova
Oxana Kytikova
Background — The development of systemic inflammation is a key pathogenetic mechanism in progression of chronic obstructive pulmonary disease (COPD). Fatty acids (FAs) and their oxidized derivatives serve as essential regulators of inflammation. The relationship between systemic inflammation and FA metabolism in COPD is poorly understood. In our research, we focused on examining the FA composition of the leukocyte membrane in COPD and the FA metabolism in association with systemic inflammation. Objective — We examined 137 patients with mild, moderate, or severe COPD. The control group comprised 32 healthy non-smokers. Methods — Blood cytokines and immune cell subpopulations were evaluated by flow cytometry. The FA composition of the leukocyte membranes was analyzed by gas chromatography. The concentrations of eicosanoids (thromboxane B2 (TXB2), leukotriene B4 (LTB4)) in plasma were measured by ELISA. Results — Our results implied systemic inflammation in all patients with COPD. The analysis of the FA composition of leukocyte membrane demonstrated increased level of saturated FAs and n-6 polyunsaturated fatty acids (PUFAs), along with reduced levels of monounsaturated FAs and n-3 PUFAs, in patients with COPD. The TXB2 and LTB4 content was increasing in COPD patients. We established a significant correlation with n-6 PUFAs, immune cells, and cytokines, which was indicative of an important role of FAs in the progress of systemic inflammation in COPD. Conclusion — Thus, FA modification of immune cells in patients with chronic pathologies of the bronchopulmonary system leads not only to disruption of the cell membrane structure, but also to the pathology of immune response regulation, and contributes to the development of the inflammatory process. The latter is a decisive factor in the pathogenesis of COPD.